As of January 2025 Adaptimmune Therapeutics has a market cap of ₹12.70 Billion. This makes Adaptimmune Therapeutics the world's 8624th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 21st, 2025 the market cap of Adaptimmune Therapeutics was reported to be: